Review Article
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Table 1
Natural compounds with therapeutic action against neurodegeneration disorders.
| Compounds | Therapeutic target | Mechanism of action | Reference |
| Coenzyme q10 | PD | α-Tocopheroxyl radical reduction and regeneration of α-tocopherol Suppression of nigrostriatal dopaminergic cell death | [9, 110, 113] | Luteolin | PD | Increases dopamine uptake | [139] | Resveratrol | PD, AD | Nrf2 activation | [115, 116, 123, 135] | Curcumin | PD | Nrf2 activation | [123] | Epigallocatechin gallate | PD | Nrf2 activation | [123] | α-Tocopherol | AD | Proteolytic degradation of Aβ plaques | [130–133] | Quercetin | PD | Scavenges hydroxyl radicals | [140] | Selenium | AD | Proteolytic degradation of Aβ plaques | [130–133] | 8-Hydroxyquinoline derivative | AD | Inhibit Aβ fibril formation and aggregation | [82] | N-(4-Phenoxybenzyl) aniline derivative | AD | Inhibition of acetylcholinesterase | [137] |
|
|